Phase I/II study of Tiotropium-bromide inhalation in Chronic-obstructive-pulmonary-disease.
Phase of Trial: Phase I/II
Latest Information Update: 13 Jun 2018
Price : $35 *
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Therapeutic Use
- 13 Jun 2018 New trial record
- 07 Jun 2018 According to the Pulmatrix media release, this study will start around year end.